Nutra Pharma Corp (NPHC) Other Operating Expenses (2010 - 2026)

Nutra Pharma has disclosed Other Operating Expenses across 11 years of filings, most recently posting $437839.0 for Q2 2026.

• In Q2 2026, Other Operating Expenses rose 1193.78% year-over-year to $437839.0; the TTM figure through Jun 2026 stood at $1.3 million (up 1697.72% YoY), while the FY2025 annual figure was $1.5 million, up 1620.46% from the prior year.
• Other Operating Expenses came in at $437839.0 for Q2 2026 at Nutra Pharma, up from $373774.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $454007.0 in Q4 2025 to a low of -$40030.0 in Q2 2025.
• Average Other Operating Expenses over 4 years is $151518.6, with a median of $71796.0 recorded in 2022.
• Year-over-year, Other Operating Expenses gained 8.99% in 2022 and jumped 1193.78% in 2026.
• Over 4 years, Other Operating Expenses stood at $71796.0 in 2022, then soared by 46.9% to $105465.0 in 2023, then jumped by 330.48% to $454007.0 in 2025, then fell by 3.56% to $437839.0 in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $437839.0 in Q2 2026, $373774.0 in Q1 2026, and $454007.0 in Q4 2025.